Vulvar intraepithelial neoplasia
Therapeutic area
Oncology
Rare disease
Yes
- Definition
- Intraepithelial neoplasia of the vulvar squamous epithelium. There is no evidence of invasion. This category includes vulvar high grade squamous intraepithelial lesion and vulvar intraepithelial neoplasia, differentiated type.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Vulvar intraepithelial neoplasia
- Therapeutic area
- Oncology
- vulvar intraepithelial neoplasia
- VIN
- intraepithelial neoplasia of the vulva
- intraepithelial neoplasia of vulva
- squamous vulvar intraepithelial neoplasia
- vulva intraepithelial neoplasia
- vulval intraepithelial neoplasia
- vulvar intraepithelial tumor
- vulvar intraepithelial tumour
- Severity
- Moderate
- Oncology
- Reproductive Health
- MONDO ID
- MONDO:0005198
- Parent condition
- MONDO:0002195
Related records
Broader conditions (16)
- Cancer or benign tumor
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Epithelial neoplasm
- Female reproductive system disorder
- Female reproductive system neoplasm
- Human disease
- Neoplasm
- Neoplastic disease or syndrome
- Reproductive system disorder
- Reproductive system neoplasm
- Squamous cell neoplasm
- Vulvar disease
- Vulvar neoplasm
- Vulvar squamous neoplasm
Narrower conditions (1)
- Low grade vulvar intraepithelial neoplasia
Trials (20)
- A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
- Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)
- Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer
- Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study
- Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study
- Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine
- Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia
- Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)
- Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
- Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
- Interest of the Confocal Microscope in the Diagnosis of Epidermoid Carcinoma of the Vulva and Their Precursors
- Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
- Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9
- Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia
- SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma
- The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
- The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
- The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence
- Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia
Drugs in development (3)
- Bizalimogene ralaplasmid Phase 2
- Imiquimod Phase 3
- Omiganan Phase 2